Crinetics
CRNX · NASDAQ
Bulios Fair Price
$51.18
39.8% downside
Trenutna cena
$84.95
Po podatkih Bulios Fair Price je delnica CRNX trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
AI poročilo o poslu, financah, vrednotenju, razpoloženju, novicah in tveganjih - napisano v nekaj minutah.
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
Crinetics Pharmaceuticals, Inc. is a biotechnology company focused on developing therapeutics for the treatment of endocrine and metabolic disorders. The company specializes in discovering and developing new drugs that modulate G-protein-coupled receptors, which are key mechanisms for regulating hormonal signaling in the body. Crinetics focuses on developing treatments for diseases such as acromegaly (caused by excessive growth hormone secretion), Cushing’s disease, and other hormonal disorders. The company's goal is to provide innovative treatment options for patients with these rare conditions.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Biotechnology
CEO
R. Scott Struthers
Employees
594
Headquarters
San Diego
Prihajajoči dogodki
Earnings
Upcoming earnings report